Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Latrofa

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
Journal of Endocrinological Investigation|October 7, 2024
Long-term outcome of Graves' orbitopathy following treatment with sirolimusSimone Comi, Giada Cosentino, Giulia Lanzolla, et al.
Thyroid : Official Journal of the American Thyroid Association|August 29, 2013
Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisitedFrancesca Menconi, Maria Antonietta Profilo, Marenza Leo, et al.
Thyroid : Official Journal of the American Thyroid Association|August 23, 2018
Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant CytologyTeresa Rago, Maria Scutari, Valeria Loiacono, et al.
European Journal of Endocrinology|July 28, 2020
Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: a 10-year follow-up studyMario Rotondi, Gloria Groppelli, Laura Croce, et al.
Thyroid : Official Journal of the American Thyroid Association|June 5, 2018
Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without <sup>131</sup>I AblationAntonio Matrone, Francesco Latrofa, Liborio Torregrossa, et al.
Thyroid : Official Journal of the American Thyroid Association|January 14, 2015
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral centerMarenza Leo, Francesca Menconi, Roberto Rocchi, et al.
Thyroid : Official Journal of the American Thyroid Association|June 20, 2015
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' OrbitopathyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2020
Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with RadioiodineAntonio Matrone, Alessio Faranda, Francesco Latrofa, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2011
Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trialMarenza Leo, Claudio Marcocci, Aldo Pinchera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 5, 2025
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort StudyGiada Cosentino, Giulia Lanzolla, Simone Comi, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
Journal of Endocrinological Investigation|October 7, 2024
Long-term outcome of Graves' orbitopathy following treatment with sirolimusSimone Comi, Giada Cosentino, Giulia Lanzolla, et al.
Thyroid : Official Journal of the American Thyroid Association|August 29, 2013
Spontaneous improvement of untreated mild Graves' ophthalmopathy: Rundle's curve revisitedFrancesca Menconi, Maria Antonietta Profilo, Marenza Leo, et al.
Thyroid : Official Journal of the American Thyroid Association|August 23, 2018
Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant CytologyTeresa Rago, Maria Scutari, Valeria Loiacono, et al.
European Journal of Endocrinology|July 28, 2020
Patients with chronic autoimmune thyroiditis are not at higher risk for developing clinically overt thyroid cancer: a 10-year follow-up studyMario Rotondi, Gloria Groppelli, Laura Croce, et al.
Thyroid : Official Journal of the American Thyroid Association|June 5, 2018
Changing Trend of Thyroglobulin Antibodies in Patients With Differentiated Thyroid Cancer Treated With Total Thyroidectomy Without <sup>131</sup>I AblationAntonio Matrone, Francesco Latrofa, Liborio Torregrossa, et al.
Thyroid : Official Journal of the American Thyroid Association|January 14, 2015
Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral centerMarenza Leo, Francesca Menconi, Roberto Rocchi, et al.
Thyroid : Official Journal of the American Thyroid Association|June 20, 2015
Age and Dose Are Major Risk Factors for Liver Damage Associated with Intravenous Glucocorticoid Pulse Therapy for Graves' OrbitopathyEleonora Sisti, Barbara Coco, Francesca Menconi, et al.
The Journal of Clinical Endocrinology and Metabolism|May 27, 2020
Thyroglobulin Changes are Highly Dependent on TSH in Low-risk DTC Patients not Treated with RadioiodineAntonio Matrone, Alessio Faranda, Francesco Latrofa, et al.
The Journal of Clinical Endocrinology and Metabolism|October 28, 2011
Outcome of Graves' orbitopathy after total thyroid ablation and glucocorticoid treatment: follow-up of a randomized clinical trialMarenza Leo, Claudio Marcocci, Aldo Pinchera, et al.
Thyroid : Official Journal of the American Thyroid Association|February 5, 2025
Ablative Versus Conservative Approach for Hyperthyroidism Treatment in Patients with Graves' Orbitopathy: A Retrospective Cohort StudyGiada Cosentino, Giulia Lanzolla, Simone Comi, et al.
Pageof 7